BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27174013)

  • 21. Anaplastic lymphoma kinase protein expression, genetic abnormalities, and phosphorylation in soft tissue tumors: Phosphorylation is associated with recurrent metastasis.
    Ishibashi Y; Miyoshi H; Hiraoka K; Arakawa F; Haraguchi T; Nakashima S; Hashiguchi T; Shoda T; Hamada T; Okawa T; Higuchi F; Shiba N; Nagata K; Ohshima K
    Oncol Rep; 2015 Apr; 33(4):1667-74. PubMed ID: 25683346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic screening identifies a 2-gene signature as a high-potential prognostic marker of undifferentiated pleomorphic sarcoma/myxofibrosarcoma.
    Hu Q; Zhou S; Hu X; Zhang H; Huang S; Wang Y
    J Cell Mol Med; 2020 Jan; 24(1):1010-1021. PubMed ID: 31742892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid identification of protein biomarkers of Escherichia coli O157:H7 by matrix-assisted laser desorption ionization-time-of-flight-time-of-flight mass spectrometry and top-down proteomics.
    Fagerquist CK; Garbus BR; Miller WG; Williams KE; Yee E; Bates AH; Boyle S; Harden LA; Cooley MB; Mandrell RE
    Anal Chem; 2010 Apr; 82(7):2717-25. PubMed ID: 20232878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinically Relevant Molecular Subtypes in Leiomyosarcoma.
    Guo X; Jo VY; Mills AM; Zhu SX; Lee CH; Espinosa I; Nucci MR; Varma S; Forgó E; Hastie T; Anderson S; Ganjoo K; Beck AH; West RB; Fletcher CD; van de Rijn M
    Clin Cancer Res; 2015 Aug; 21(15):3501-11. PubMed ID: 25896974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
    Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
    Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia-inducible factor 1α predicts recurrence in high-grade soft tissue sarcoma of extremities and trunk wall.
    Nyström H; Jönsson M; Werner-Hartman L; Nilbert M; Carneiro A
    J Clin Pathol; 2017 Oct; 70(10):879-885. PubMed ID: 28404817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laser ionization mass spectrometry in oral squamous cell carcinoma.
    Seema S; Krishnan M; Harith AK; Sahai K; Iyer SR; Arora V; Tripathi RP
    J Oral Pathol Med; 2014 Aug; 43(7):471-83. PubMed ID: 24112294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germinal GLT8D1, GATAD2A and SLC25A39 mutations in a patient with a glomangiopericytal tumor and five different sarcomas over a 10-year period.
    Beddok A; Pérot G; Le Guellec S; Thebault N; Coutte A; Sevestre H; Chauffert B; Chibon F
    Sci Rep; 2021 May; 11(1):9765. PubMed ID: 33963205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TOP2A copy number and TOP2A expression in uterine benign smooth muscle tumours and leiomyosarcoma.
    Baiocchi G; Poliseli FL; De Brot L; Mantoan H; Schiavon BN; Faloppa CC; Vassallo J; Soares FA; Cunha IW
    J Clin Pathol; 2016 Oct; 69(10):884-9. PubMed ID: 26994023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new tumor biomarker, serum protein peak at 3,144 m/z, in patients with node-positive breast cancer.
    Chen Z; Xu S; Su D; Liu W; Yang H; Xie S; Meng X; Lei L; Wang X
    Clin Transl Oncol; 2015 Jun; 17(6):486-94. PubMed ID: 25511546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical margins do not affect prognosis in high grade myxofibrosarcoma.
    Sambri A; Bianchi G; Righi A; Ferrari C; Donati D
    Eur J Surg Oncol; 2016 Jul; 42(7):1042-8. PubMed ID: 27260849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma.
    De Sanctis R; Marrari A; Marchetti S; Mussi C; Balzarini L; Lutman FR; Daolio P; Bastoni S; Bertuzzi AF; Quagliuolo V; Santoro A
    Drug Des Devel Ther; 2015; 9():5785-91. PubMed ID: 26604682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MALDI imaging mass spectrometry reveals multiple clinically relevant masses in colorectal cancer using large-scale tissue microarrays.
    Hinsch A; Buchholz M; Odinga S; Borkowski C; Koop C; Izbicki JR; Wurlitzer M; Krech T; Wilczak W; Steurer S; Jacobsen F; Burandt EC; Stahl P; Simon R; Sauter G; Schlüter H
    J Mass Spectrom; 2017 Mar; 52(3):165-173. PubMed ID: 28117928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of SELDI-TOF in N-glycopeptides profiling of the urine from patients with endometrial, ovarian and cervical cancer.
    Mu AK; Lim BK; Aminudin N; Hashim OH; Shuib AS
    Arch Physiol Biochem; 2016 Jul; 122(3):111-6. PubMed ID: 26849673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative Study of Myxofibrosarcoma With Undifferentiated Pleomorphic Sarcoma: Histopathologic and Clinicopathologic Review.
    Yoshimoto M; Yamada Y; Ishihara S; Kohashi K; Toda Y; Ito Y; Yamamoto H; Furue M; Nakashima Y; Oda Y
    Am J Surg Pathol; 2020 Jan; 44(1):87-97. PubMed ID: 31651522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leiomyosarcoma and sarcoma with myogenic differentiation: two different entities or 2 faces of the same disease?
    Colombo C; Miceli R; Collini P; Radaelli S; Palassini E; Stacchiotti S; Fiore M; Mariani L; Casali PG; Gronchi A
    Cancer; 2012 Nov; 118(21):5349-57. PubMed ID: 22517186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retroperitoneal malignant mesenchymoma: a case of mesenchymal mixed tumor with osteosarcoma, leiomyosarcoma, liposarcoma and fibrosarcoma.
    Choi JE; Chung HJ; Yoo WJ; Chung MH; Sung MS; Lee HG; Park IY; Kim J
    Korean J Radiol; 2002; 3(4):264-6. PubMed ID: 12514345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple statistical analysis techniques corroborate intratumor heterogeneity in imaging mass spectrometry datasets of myxofibrosarcoma.
    Jones EA; van Remoortere A; van Zeijl RJ; Hogendoorn PC; Bovée JV; Deelder AM; McDonnell LA
    PLoS One; 2011; 6(9):e24913. PubMed ID: 21980364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MALDI mass spectrometry in prostate cancer biomarker discovery.
    Flatley B; Malone P; Cramer R
    Biochim Biophys Acta; 2014 May; 1844(5):940-9. PubMed ID: 23831156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In situ proteomic analysis by MALDI imaging identifies ubiquitin and thymosin-β4 as markers of malignant intraductal pancreatic mucinous neoplasms.
    Rebours V; Le Faouder J; Laouirem S; Mebarki M; Albuquerque M; Camadro JM; Léger T; Ruszniewski P; Lévy P; Paradis V; Bedossa P; Couvelard A
    Pancreatology; 2014; 14(2):117-24. PubMed ID: 24650966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.